97 related articles for article (PubMed ID: 20560774)
1. Polymeric nanospheres modified with YIGSR peptide for tumor targeting.
Dubey PK; Singodia D; Vyas SP
Drug Deliv; 2010; 17(7):541-51. PubMed ID: 20560774
[TBL] [Abstract][Full Text] [Related]
2. Liposomes modified with YIGSR peptide for tumor targeting.
Dubey PK; Singodia D; Vyas SP
J Drug Target; 2010 Jun; 18(5):373-80. PubMed ID: 20020817
[TBL] [Abstract][Full Text] [Related]
3. Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin.
Sarfati G; Dvir T; Elkabets M; Apte RN; Cohen S
Biomaterials; 2011 Jan; 32(1):152-61. PubMed ID: 20889205
[TBL] [Abstract][Full Text] [Related]
4. RGD modified albumin nanospheres for tumour vasculature targeting.
Dubey PK; Singodia D; Verma RK; Vyas SP
J Pharm Pharmacol; 2011 Jan; 63(1):33-40. PubMed ID: 21155813
[TBL] [Abstract][Full Text] [Related]
5. Liposomes modified with cyclic RGD peptide for tumor targeting.
Dubey PK; Mishra V; Jain S; Mahor S; Vyas SP
J Drug Target; 2004 Jun; 12(5):257-64. PubMed ID: 15512776
[TBL] [Abstract][Full Text] [Related]
6. Bioconjugation of laminin-related peptide YIGSR with polyvinyl pyrrolidone increases its antimetastatic effect due to a longer plasma half-life.
Mu Y; Kamada H; Kodaira H; Sato K; Tsutsumi Y; Maeda M; Kawasaki K; Nomizu M; Yamada Y; Mayumi T
Biochem Biophys Res Commun; 1999 Nov; 264(3):763-7. PubMed ID: 10544005
[TBL] [Abstract][Full Text] [Related]
7. Laminin receptor-targeted etoposide loaded polymeric micelles: a novel approach for the effective treatment of tumor metastasis.
Ukawala M; Chaudhari K; Rajyaguru T; Manjappa AS; Murthy RS; Gude R
J Drug Target; 2012 Jan; 20(1):55-66. PubMed ID: 21967151
[TBL] [Abstract][Full Text] [Related]
8. Antiidiotypic antibodies carrying the "internal image" of peptide YIGSR inhibit spontaneous metastasis of Lewis lung carcinoma in mice.
Koliakos KK; Sapountzi Z; Papageorgiou A; Trachana V; Kotsinou S; Koliakos G
In Vivo; 2002; 16(6):511-8. PubMed ID: 12494895
[TBL] [Abstract][Full Text] [Related]
9. Amino acids and peptides. XXXIII. A bifunctional poly(ethylene glycol) hybrid of laminin-related peptides.
Maeda M; Kawasaki K; Mu Y; Kamada H; Tsutsumi Y; Smith TJ; Mayumi T
Biochem Biophys Res Commun; 1998 Jul; 248(3):485-9. PubMed ID: 9703952
[TBL] [Abstract][Full Text] [Related]
10. Synthetic cell-adhesive laminin peptide YIGSR conjugated with polyethylene glycol has improved antimetastatic activity due to a longer half-life in blood.
Kaneda Y; Yamamoto S; Kihira T; Tsutsumi Y; Nakagawa S; Miyake M; Kawasaki K; Mayumi T
Invasion Metastasis; 1995; 15(3-4):156-62. PubMed ID: 8621271
[TBL] [Abstract][Full Text] [Related]
11. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
Lopez-Barcons LA; Polo D; Reig F; Fabra A
J Biomed Mater Res A; 2004 Apr; 69(1):155-63. PubMed ID: 14999763
[TBL] [Abstract][Full Text] [Related]
12. Multimeric forms of Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide enhance the inhibition of tumor growth and metastasis.
Nomizu M; Yamamura K; Kleinman HK; Yamada Y
Cancer Res; 1993 Aug; 53(15):3459-61. PubMed ID: 8339246
[TBL] [Abstract][Full Text] [Related]
13. Effect of Matrigel and laminin peptide YIGSR on tumor growth and metastasis.
Yamamura K; Kibbey MC; Jun SH; Kleinman HK
Semin Cancer Biol; 1993 Aug; 4(4):259-65. PubMed ID: 8400148
[TBL] [Abstract][Full Text] [Related]
14. New analogues of laminin active fragment YIGSR: synthesis and biological activity in vitro and in vivo.
Witkowska E; Oriowska A; Izdebski J; Salwa J; Wietrzyk J; Opolski A
J Pept Sci; 2004 May; 10(5):285-90. PubMed ID: 15160840
[TBL] [Abstract][Full Text] [Related]
15. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
16. In vivo binding of the radioiodinated peptide YIGSR on B16 melanoma cells.
Kouzi-Koliakos K; Koliakos G; Trontzos C; Papageorgiou A; Iliadis S; Triantos A; Dimitriadou A; Kanellaki M
Invasion Metastasis; 1996; 16(6):322-9. PubMed ID: 9371232
[TBL] [Abstract][Full Text] [Related]
17. TMTP1, a novel tumor-homing peptide specifically targeting metastasis.
Yang W; Luo D; Wang S; Wang R; Chen R; Liu Y; Zhu T; Ma X; Liu R; Xu G; Meng L; Lu Y; Zhou J; Ma D
Clin Cancer Res; 2008 Sep; 14(17):5494-502. PubMed ID: 18765541
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291.
Naglich JG; Jure-Kunkel M; Gupta E; Fargnoli J; Henderson AJ; Lewin AC; Talbott R; Baxter A; Bird J; Savopoulos R; Wills R; Kramer RA; Trail PA
Cancer Res; 2001 Dec; 61(23):8480-5. PubMed ID: 11731431
[TBL] [Abstract][Full Text] [Related]
19. Bioconjugation of laminin peptide YIGSR with poly(styrene co-maleic acid) increases its antimetastatic effect on lung metastasis of B16-BL6 melanoma cells.
Mu Y; Kamada H; Kaneda Y; Yamamoto Y; Kodaira H; Tsunoda S; Tsutsumi Y; Maeda M; Kawasaki K; Nomizu M; Yamada Y; Mayumi T
Biochem Biophys Res Commun; 1999 Feb; 255(1):75-9. PubMed ID: 10082658
[TBL] [Abstract][Full Text] [Related]
20. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
Sheu JR; Fu CC; Tsai ML; Chung WJ
Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
